RASSF6 (Ras association domain family member 6) functions as a tumor suppressor protein that regulates apoptosis and cell cycle progression through multiple pathways. The protein induces both caspase-dependent and caspase-independent apoptosis 1 and mediates cell cycle arrest via the retinoblastoma (pRb) pathway by enhancing pRb-protein phosphatase interactions and suppressing BMI1 to increase P16INK4A and P14ARF expression 2. RASSF6 also regulates p53-mediated responses by blocking MDM2-mediated p53 degradation and facilitating nuclear accumulation following DNA damage through CDK9-mediated BAF53 phosphorylation, ultimately promoting p53 target gene transcription via SWI/SNF complex interactions 3. The protein cross-talks with the Hippo signaling pathway by downregulating YAP, affecting mitochondrial membrane potential and doxorubicin sensitivity 1. RASSF6 is frequently downregulated through promoter hypermethylation in various cancers including bladder cancer, neuroblastoma, and acute lymphoblastic leukemia 145. In normal tissues, RASSF6 localizes to kidney glomeruli and renal proximal tubular epithelial cell apical membranes, where it participates in sorbitol-induced apoptosis 6. The protein's tumor suppressor function operates through both p53-dependent and p53-independent mechanisms, making it a critical regulator of cellular homeostasis.